N
Patient 1
AS STATED IN THE DESCRIBE EVENT SECTION, EACH ELECTRODE WAS PULLED TO DELIVER IT THROUGH THE EXITING STAB INCISION MADE DURING THE INITIAL SURGERY. THE FOLLOWING ELECTRODES WERE USED IN THE SURGERY: CATALOG NUMBER: TS04R-SP10X-000, LOT #: 208140624, QTY: 4, EXP. DATE: 2018-10-01, (B)(4); TS04R-SP10X-000, 208140593, 1, 2017/08, N/A (THIS LOT WAS MANUFACTURED PRIOR TO THE IMPLEMENTATION OF UDI); TS04R-SP10X-000, 208140623, 1, 2018/09, N/A (THIS LOT WAS MANUFACTURED PRIOR TO THE IMPLEMENTATION OF UDI). PRIOR TO THIS COMPLAINT, AD-TECH HAD RECEIVED SEVERAL COMPLAINTS OF SIMILAR NATURE. DUE TO THE NUMBER OF COMPLAINTS RECEIVED, A CORRECTIVE ACTION/PREVENTIVE ACTION (CAPA) INVESTIGATION WAS INITIATED TO ADDRESS THIS ISSUE IN MAY 2014. THE PROBABLE ROOT CAUSE FOR THIS ISSUE (DISC DISLODGEMENT) WAS FOUND TO BE DUE TO PERCUTANEOUS REMOVAL OF THE ELECTRODES BY THE END USER; AD-TECH'S DIRECTIONS FOR USE (DFU) SPECIFICALLY STATES THAT AD-TECH'S SUBDURAL STRIP ELECTRODES BE REMOVED SURGICALLY. AS A CORRECTION TO THE CAPA, THE FOLLOWING WARNING STATEMENT WAS INCORPORATED INTO AD-TECH'S DFU IN JUNE 2014, "WARNING: PERCUTANEOUS REMOVAL MAY RESULT IN THE SEPARATION OF MATERIALS, REQUIRING SURGICAL INTERVENTION TO RETRIEVE THE ELECTRODE AND CONTACTS." A MEMO WAS SENT TO ALL AD-TECH NEUROSURGEON CUSTOMERS INFORMING THEM OF THE ADDITION TO THE DFU IN JUNE 2014. IT WAS CONFIRMED THAT THE HOSPITAL ACKNOWLEDGED NOTIFICATION OF THIS ADDITION ON 7/14/2014. ON 10/9/2017, AD-TECH SENT THE HOSPITAL AN EMAIL REITERATING THE IMPORTANCE OF SURGICALLY REMOVING THE ELECTRODES AND NOT PERCUTANEOUSLY REMOVING THEM. THE DIRECTIONS FOR USE (DFU) WAS ALSO ATTACHED TO THE EMAIL SHOWING THE WARNING.